OTC Events

Nationwide Children’s Hospital Therapeutics Showcase

March 7, 2019: 1 – 5 pm
The Blackwell at The Ohio State University
2110 Tuttle Park Place, Columbus, Ohio 43210

  • The latest discoveries in pediatric therapeutic interventions
  • Networking with physicians, scientists and investors
  • Post-event reception

Presentations

“TransJoin™ and TransScript™: Bringing the Power of AAV to Cancer Therapy"

New technologies are in development that enable tunable transgene expression for adeno-associated virus (AAV)-based gene therapy applications and specifically for a new platform of AAV-based cancer treatments.

Presenter

Timothy P. Cripe, MD, PhD
Division Chief, Hematology/Oncology/BMT, Nationwide Children's Hospital
Professor of Pediatrics, The Ohio State University

"TGFβ Imprinting: A New Method to Generate Natural Killer Cells with Enhanced Anti-Cancer Potential"

A new way has been identified to generate NK cells for clinical use, making them resistant to TGFβ (a protein produced by cancer cells that is like Kryptonite to the immune system), and allowing them to retain their cancer-killing function in these toxic environments.

Presenter

Dean Lee, MD, PhD
Director, Cellular Therapy and Cancer Immunology Program, Nationwide Children's Hospital
Professor of Pediatrics, The Ohio State University

"The Role of Serendipity in Discovery"

A powerful novel immunomodulator has been discovered based on altering the Lysosomal Trafficking Regulator (LYST) gene with significant and broad therapeutic applications.

Presenter

Christopher Breuer, MD
Director, Center for Regenerative Medicine, Nationwide Children's Hospital
Professor of Pediatric Surgery, The Ohio State University

“A Novel Vaccine to Protect Young Children from Respiratory Syncytial Virus"

A group of seven investigators is attacking RSV from four sides, using the most recent understanding of RSV biology to produce a live attenuated RSV vaccine that is safe and induces the highest possible level of long-lasting protection.

Presenters

Mark E. Peeples, PhD
Principal Investigator, Center for Vaccines and Immunity, Nationwide Children's Hospital
Professor of Pediatrics, The Ohio State University

Octavio Ramilo, MD
Division Chief, Infectious Diseases, and Principal Investigator, Center for Vaccines and Immunity, Nationwide Children's Hospital
Professor of Pediatrics, The Ohio State University

“Translating Gene Therapy for Facioscapulohumeral Muscular Dystrophy"

Discover more about gene therapies to treat FSHD, a devastating disorder affecting more than 870,000 people worldwide.

Presenter

Scott Q. Harper, PhD
Principal Investigator, Center for Gene Therapy, Nationwide Children's Hospital
Associate Professor of Pediatrics, The Ohio State University

“A Novel Therapeutic Strategy for Bacterial Infections"

A novel platform therapeutic has been developed for the disruption of bacterial biofilms which can be used to treat a variety of bacterial infections.
(Speaker to be announced)

Panel Discussion

“Affordability and Accessibility of Curative Therapies"

  • David Lennon, PhD, President, AveXis
  • Julie Kendle, PharmD, Pharmacy Director in Clinical Drug Assessment, AETNA
  • Michael Storey, PharmD, MS, BCPS, Coordinator, Medication Use and Formulary Management, Nationwide Children's Hospital
  • Moderator: Chet Kaczor, PharmD, MBA, Chief Pharmacy Officer, Nationwide Children’s Hospital
Questions? Email the event organizers at techshowcase@nationwidechildrens.org

Also, save May 9, 2019, for the Nationwide Children’s End User Innovation Showcase hosted in partnership with OhioHealth.

RSVP Today